#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	16330	16S	1529	1529	100.0	16S.l15.c30.ctg.1	2326	700.6	1	SNP	n	C1184T	0	.	.	1184	1184	C	1551	1551	C	947	C,G	870,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	16330	16S	1529	1529	100.0	16S.l15.c30.ctg.1	2326	700.6	0	HET	.	.	.	A69G	.	69	69	A	436	436	A	937	A,G	677,187	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	29692	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3554	833.1	0	.	n	.	0	T695C	SNP	695	695	T	1003	1003	C	951	C,T	885,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	29692	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3554	833.1	0	.	n	.	0	G1337A	SNP	1337	1337	G	1645	1645	A	1014	A	938	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	29692	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3554	833.1	0	.	n	.	0	T1971C	SNP	1971	1971	T	2279	2279	C	975	C,T,G	887,1,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	29692	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3554	833.1	1	SNP	n	A2045G	0	.	.	2045	2045	A	2353	2353	A	970	A	902	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	29692	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3554	833.1	1	SNP	n	C2597T	0	.	.	2597	2597	C	2905	2905	C	950	C	887	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_Y_01480c	folP.WHO_Y_01480c	1	1	27	2110	folP	855	855	100.0	folP.l15.c4.ctg.1	1564	134.4	1	SNP	p	R229S	1	.	.	685	687	AGC	983	985	AGC	193;193;193	A;G,T;C	181;180,1;179	folP.WHO_Y_01480c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5466	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3352	162.6	1	SNP	p	S91F	1	.	.	271	273	TTC	508	510	TTC	206;204;204	T;T,C;C	189;187,1;187	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5466	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3352	162.6	1	SNP	p	D95G	1	.	.	283	285	GGC	520	522	GGC	194;196;197	G;G,A;C	180;175,1;177	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5466	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3352	162.6	1	SNP	p	G95N	0	.	.	283	285	GGC	520	522	GGC	194;196;197	G;G,A;C	180;175,1;177	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_X_01389	mtrR.WHO_X_01389	1	1	27	1874	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1312	142.6	1	SNP	p	G45D	0	.	.	133	135	GGC	435	437	GGC	235;232;234	G;G;C	218;215;215	mtrR.WHO_X_01389:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	920	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c17.ctg.1	1038	88.2	0	.	n	.	0	A197.	DEL	197	197	A	638	638	A	214	A	199	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5478	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3028	180.5	1	SNP	p	D86N	0	.	.	256	258	GAC	640	642	GAC	178;180;179	G;A;C	162;162;164	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5478	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3028	180.5	1	SNP	p	S87R	1	.	.	259	261	CGT	643	645	CGT	178;178;178	C;G;T	163;165;161	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5478	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3028	180.5	1	SNP	p	R87I	0	.	.	259	261	CGT	643	645	CGT	178;178;178	C;G;T	163;165;161	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5478	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3028	180.5	1	SNP	p	R87W	0	.	.	259	261	CGT	643	645	CGT	178;178;178	C;G;T	163;165;161	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5478	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3028	180.5	1	SNP	p	S88P	0	.	.	262	264	TCC	646	648	TCC	180;179;181	T;C;C	163;162;167	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4576	parE	1986	1986	100.0	parE.l15.c30.ctg.1	2642	172.5	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1512	1514	GGC	230;231;229	G;G;C	207;209;208	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.5.002	penA.5.002	1	1	27	4286	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2369	180.5	1	SNP	p	A311V	0	.	.	931	933	GCA	1230	1232	GCA	231;233;235	G;C;A	208;214;217	penA.5.002:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4286	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2369	180.5	1	SNP	p	I312M	0	.	.	934	936	ATC	1233	1235	ATC	234;233;237	A;T;C	215;215;217	penA.5.002:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4286	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2369	180.5	1	SNP	p	V316P	0	.	.	946	948	GTG	1245	1247	GTG	236;235;234	G;T;G	221;218;213	penA.5.002:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4286	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2369	180.5	1	SNP	p	V316T	0	.	.	946	948	GTG	1245	1247	GTG	236;235;234	G;T;G	221;218;213	penA.5.002:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4286	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2369	180.5	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1749	1751	ACC	202;203;203	A;C;C	182;187;188	penA.5.002:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4286	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2369	180.5	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1803	1805	GCG	211;212;212	G;C,G;G	191;169,1;181	penA.5.002:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4286	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2369	180.5	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1803	1805	GCG	211;212;212	G;C,G;G	191;169,1;181	penA.5.002:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4286	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2369	180.5	1	SNP	p	G543S	1	.	.	1627	1629	AGC	1926	1928	AGC	196;196;196	A;G;C	183;181;182	penA.5.002:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4286	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2369	180.5	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1935	1937	GGC	193;193;190	G;G;C	173;173;170	penA.5.002:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4286	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2369	180.5	1	SNP	p	P552S	0	.	.	1654	1656	CCG	1953	1955	CCG	159;159;159	C,G,A;C;G	107,3,1;113;113	penA.5.002:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	6158	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3078	199.3	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1586	1588	CCG	204;205;205	C;C,T;G	189;191,2;189	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2348	porA	1146	1146	99.91	porA.l15.c4.ctg.1	1724	135.2	0	.	p	.	0	M83fs	FSHIFT	247	247	A	516	516	C	186	C,T	166,1	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3198	porB1b	1047	1047	99.24	porB1b.l6.c30.ctg.1	1357	229.0	0	.	p	.	0	N38E	NONSYN	112	114	AAT	265	267	GAA	273;274;274	G;A;A	246;251;250	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3198	porB1b	1047	1047	99.24	porB1b.l6.c30.ctg.1	1357	229.0	0	.	p	.	0	N134D	NONSYN	400	402	AAT	553	555	GAT	254;255;253	G;A;T,G	243;241;238,1	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3198	porB1b	1047	1047	99.24	porB1b.l6.c30.ctg.1	1357	229.0	0	.	p	.	0	P175S	NONSYN	523	525	CCA	676	678	TCA	267;270;274	T;C,A,G;A	240;242,1,1;247	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3198	porB1b	1047	1047	99.24	porB1b.l6.c30.ctg.1	1357	229.0	0	.	p	.	0	A218V	NONSYN	652	654	GCC	805	807	GTC	255;252;250	G,A;T;C	237,1;236;237	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3198	porB1b	1047	1047	99.24	porB1b.l6.c30.ctg.1	1357	229.0	0	.	p	.	0	F222S	NONSYN	664	666	TTT	817	819	TCT	256;259;262	T;C,T;T,G	237;243,2;246,1	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3198	porB1b	1047	1047	99.24	porB1b.l6.c30.ctg.1	1357	229.0	0	.	p	.	0	E328A	NONSYN	982	984	GAA	1135	1137	GCA	263;261;263	G;C,A;A	243;238,1;244	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3198	porB1b	1047	1047	99.24	porB1b.l6.c30.ctg.1	1357	229.0	1	SNP	p	G120K	1	.	.	358	360	AAG	511	513	AAG	273;274;271	A;A;G	255;257;254	porB1b.WHO_V_02265c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3198	porB1b	1047	1047	99.24	porB1b.l6.c30.ctg.1	1357	229.0	1	SNP	p	D121N	0	.	.	361	363	GAC	514	516	GAC	272;271;270	G;A;C	252;253;252	porB1b.WHO_V_02265c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3198	porB1b	1047	1047	99.24	porB1b.l6.c30.ctg.1	1357	229.0	1	SNP	p	A121D	1	.	.	361	363	GAC	514	516	GAC	272;271;270	G;A;C	252;253;252	porB1b.WHO_V_02265c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	11954	rpoB	4179	4179	99.98	rpoB.l15.c30.ctg.1	4900	243.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1198	rpsJ	312	312	100.0	rpsJ.l15.c30.ctg.1	930	127.2	1	SNP	p	V57M	1	.	.	169	171	ATG	422	424	ATG	241;241;241	A;T;G	225;227;224	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
